Practice Guidelines for the Management of Bacterial Meningitis
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Abstract
In this guideline, we will review our recommendations for the diagnosis and management of bacterial meningitis.Recommendation categories are shown in table 1.The guideline represents data published through May 2004.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parameters such as CSF protein level, glucose level, and white blood cell (WBC) count may be inconsistent in differentiating viral from bacterial infections and nonspecific to provide treatment direction [9].”
From Clinical utility of a cerebrospinal fluid multiplex PCR meningitis/encephalitis panel in children: a retrospective review of positive results (2026) · cites this paper as [9]
In the citing paper
“The sensitivity of CSF Gram stain is 60% to 80% in patients without antibiotic pretreatment and decreases by 20% with antibiotic pretreatment [9].”
From Clinical utility of a cerebrospinal fluid multiplex PCR meningitis/encephalitis panel in children: a retrospective review of positive results (2026) · cites this paper as [9]
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Red Book: 2024–2027 Report of the Committee on Infectious Diseases
Committee on Infectious Diseases, A. A. O. P. (2024) · doi:10.1542/9781610027359 · Cited by 1,548
Principles and Practice of Infectious Diseases
Larson, H. E. (1980) · Journal of Clinical Pathology · doi:10.1136/jcp.33.9.907-a · Cited by 1,276
Dexamethasone in Adults with Bacterial Meningitis
de Gans, J., & van de Beek, D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021334 · Cited by 1,205
Dexamethasone Therapy for Bacterial Meningitis
Lebel, M. H., Freij, B. J., Syrogiannopoulos, G. A., Chrane, D. F., Hoyt, M. J., Stewart, S. M., Kennard, B. D., Olsen, K. D., & McCracken, G. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810133191502 · Cited by 606
Infections of the Central Nervous System
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-415_1 · Cited by 592
Self-citationOdio, C. M., Faingezicht, I., Paris, M., Nassar, M., Baltodano, A., Rogers, J., Sáez-Llorens, X., Olsen, K. D., & McCragken, G. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242201 · Cited by 501 · cited 1×
“There have been 15 published trials on the use of adjunctive dexamethasone in infants and children with bacterial meningitis [49–63].”
Aronin, S. I., Peduzzi, P., & Quagliarello, V. J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-11_part_1-199812010-00004 · Cited by 486 · cited 4×
“In the recent study in adults cited above [71], only 72% of 108 CSF pneumococcal isolates were submitted for in vitro susceptibility testing, and all were susceptible to penicillin, an unusual finding in the United States and in many areas of the world.”
InfluentialMylonakis, E., Hohmann, E. L., & Calderwood, S. B. (1998) · Medicine · doi:10.1097/00005792-199809000-00002 · Cited by 475 · cited 1×
“The likelihood of having a positive Gram stain result also depends on the specific bacterial pathogen causing meningitis [3, 10]: 90% of cases caused by Streptococcus pneumoniae, 86% of cases caused by Haemophilus influenzae, 75% of cases caused by Neisseria meningitidis, 50% of cases caused by gram-negative bacilli,…”
Current Clinical Topics in Infectious Diseases
(1984) · Archives of Internal Medicine · doi:10.1001/archinte.1984.00350150042013 · Cited by 471
Research works printed but not linked: 3
- American Academy of Pediatrics, 2003, Pneumococcal infections, 490
- Kaufman, 1997, Infections of cerebrospinal fluid shunts, 555
- Kaufman, 1997, Infections of cerebrospinal fluid shunts, 555
Cited by
Items 101–200 of 1,003
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children
Olarte, L., Barson, W. J., Barson, R. M., Lin, P. L., Romero, J. R., Tan, T. Q., Givner, L. B., Bradley, J. S., Hoffman, J. A., Hultén, K. G., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ368 · Cited by 131
“however, only 2 of them required both antibiotics based on bacterial meningitis treatment guideline recommendations [23].”
BackgroundSelf-citationThe risk of seizures among the carbapenems: a meta-analysis
Cannon, J. P., Lee, T. A., Clark, N. M., Setlak, P., & Grim, S. A. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku111 · Cited by 131
Koopmans, M. M., Brouwer, M. C., Bijlsma, M. W., Bovenkerk, S., Keijzers, W., van der Ende, A., & van de Beek, D. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit250 · Cited by 130
“pneumoniae are cultured [6, 10, 11].”
BackgroundCentral Nervous System Infections
Somand, D. M., & Meurer, W. J. (2009) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2008.07.004 · Cited by 143
Østergaard, C., Konradsen, H. B., & Samuelsson, S. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-93 · Cited by 128
“Prognostic factors associated with fatal outcome in univariate logistic regression analysis were advanced age, presence of an underlying disease, history of headache, presence of a lung focus, absence of an otogenic focus, having a CT-scan prior to lumbar puncture, convulsions, requirement of assisted ventilation, and…”
InfluentialReinhart, K., Brunkhorst, F. M., Bone, H.-G., Bardutzky, J., Dempfle, C. E., Forst, H., Gastmeier, P., Gerlach, H., Gründling, M., John, S., et al. (2010) · Der Anaesthesist · doi:10.1007/s00101-010-1719-5 · Cited by 148
Woehrl, B., Brouwer, M. C., Murr, C., Heckenberg, S. G. B., Baas, F., Pfister, H. W., Zwinderman, A. H., Morgan, B. P., Barnum, S. R., ENDE, A. V. D., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57522 · Cited by 140
Multidrug-Resistant Streptococcus pneumoniae Infections: Current and Future Therapeutic Options
Bambeke, F. V., Reinert, R., Appelbaum, P. C., Tulkens, P. M., & Peetermans, W. E. (2007) · Drugs · doi:10.2165/00003495-200767160-00005 · Cited by 133
Central Nervous System Infections: Meningitis and Brain Abscess
Honda, H., & Warren, D. K. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.04.009 · Cited by 126
“therapy for community-onset bacterial meningitis in the United States is both vancomycin and a third-generation cephalosporin.(47)”
BackgroundMethodInfluentialMethods for Rapid Diagnosis of Meningitis Etiology in Adults
Poplin, V., Boulware, D. R., & Bahr, N. C. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0333 · Cited by 119
Ray, P., Badarou-Acossi, G., Viallon, A., Boutoille, D., Arthaud, M., Trystram, D., & Riou, B. (2007) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2006.07.012 · Cited by 120
“Immediately after the diagnosis of meningitis was established, patients in whom a BM could not be ruled out were treated with antibiotic drugs, usually with a thirdgeneration cephalosporin (cefotaxime or ceftriaxone) with amoxicillin and/or vancomycin according to national and international recommendations [1].”
BackgroundMethodInfluentialStaphylococcus epidermidis and Other Coagulase-Negative Staphylococci
Rupp, M. E., & Fey, P. D. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00197-1 · Cited by 124
Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital.
du Plessis, T., Walls, G., Jordan, A., & Holland, D. J. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky575 · Cited by 117
Propionibacterium acnes: an under-appreciated cause of post-neurosurgical infection
Nisbet, M., Briggs, S. E., Ellis-Pegler, R. B., Thomas, M., & Holland, D. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm351 · Cited by 117
“acnes meningitis not associated with bone flap infection received a shorter duration of treatment, again broadly in line with recommendations for the management of meningitis.(16) It seems intuitively unlikely that bone-flap-associated infection without intracranial complications and where the bone flap has been remov…”
BackgroundRadmard, S., Reid, S., Ciryam, P., Boubour, A., Ho, N., Zucker, J., Sayre, D., Greendyke, W. G., Miko, B. A., Pereira, M. R., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00281 · Cited by 127
“Case definitions by organismwere based on Infectious Disease Society of America (IDSA) guidelines and included review of clinical presentation, CSF and other ancillary laboratory data, and neuroimaging findings (25).”
MethodA Guide to Bacterial Culture Identification And Results Interpretation.
Giuliano, C. A., Patel, C. R., & Kale-Pradhan, P. B. (2019) · PubMed · Cited by 193
Yealy, D. M., Mohr, N. M., Shapiro, N. I., Venkatesh, A. K., Jones, A. E., & Self, W. H. (2021) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2021.02.006 · Cited by 136
Khan, A. R., Khan, S., Zimmerman, V. A., Baddour, L. M., & Tleyjeh, I. M. (2010) · Clinical Infectious Diseases · doi:10.1086/656735 · Cited by 126
Management of Methicillin‐ResistantStaphylococcus aureusBacteremia
Cosgrove, S. E., & Fowler, V. G. (2008) · Clinical Infectious Diseases · doi:10.1086/533595 · Cited by 133
“5 mg/kg iv every 12 h [26, 27] “Red man” syndrome; neutropenia; thrombocytopenia Slowly bactericidal; treatment failures reported despite MICs in susceptible range”
BackgroundDiagnosis of reversible causes of coma
Edlow, J. A., Rabinstein, A. A., Traub, S. J., & Wijdicks, E. F. M. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62184-4 · Cited by 140
Rimawi, R. H., Mazer, M. A., Siraj, D. S., Gooch, M., & Cook, P. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31828e9863 · Cited by 129
“● CNS infections: 2004 IDSA guidelines for the management of bacterial meningitis and 2008 IDSA guidelines for encephalitis (12, 13).”
BackgroundMohanty, T., Fisher, J., Bakochi, A., Neumann, A., Cardoso, J. F. P., Karlsson, C. A. Q., Pavan, C., Lundgaard, I., Nilson, B., Reinstrup, P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09040-0 · Cited by 120
Dubos, F., Moulin, F., Gajdos, V., de Suremain, N., Biscardi, S., Lebon, P., Raymond, J., Bréart, G., Gendrel, D., & Chalumeau, M. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.02.034 · Cited by 117
Grandgirard, D., Schürch, C. M., Cottagnoud, P., & Leib, S. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01014-06 · Cited by 112
“pneumoniae strains (10, 11, 30) and the observed increase in the incidence of cephalosporin-resistant and vancomycin-tolerant strains may jeopardize the use of cefotaxime/ceftriaxone combined with vancomycin for the treatment of pneumococcal meningitis (53).”
BackgroundSiberry, G. K., Abzug, M. J., Nachman, S., Brady, M. T., Dominguez, K. L., Handelsman, E. L., MOFENSON, L. M., Nesheim, S. R., Health, N. I. O., Prevention, C. F. D. C. A., et al. (2013) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000437856.09540.11 · Cited by 120
Tapiainen, T., Prevots, D. R., Izurieta, H. S., Abramson, J. S., Bilynsky, R., Bonhoeffer, J., Bonnet, M.-C., Galama, J. M. D., Gillard, P. H., Griot, M., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.058 · Cited by 121
“In addition, ancillary tests such as measurement of CSF lactic acid, CSF or serum C-reactive protein (CRP) [49,51,52] are not used in the case definition because they are usually not available in those settings where they might increase the accuracy of the case definition, i.e., when bacterial…”
Diagnosis and Treatment of Central Nervous System Infections in the Emergency Department
Dorsett, M., & Liang, S. Y. (2016) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2016.06.013 · Cited by 110
Nishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Journal of Intensive Care · doi:10.1186/s40560-017-0270-8 · Cited by 118
“However, bacterial meningitis requires urgent treatment, and if lumbar puncture cannot be performed for some reason, administration of antimicrobials should be given priority [27].”
BackgroundMeningitis in adults: diagnosis and management
Young, N., & Thomas, M. (2018) · Internal Medicine Journal · doi:10.1111/imj.14102 · Cited by 126
Community-Acquired Bacterial Meningitis in Adults: Antibiotic Timing in Disease Course and Outcome
Lepur, D., & Baršić, B. (2007) · Infection · doi:10.1007/s15010-007-6202-0 · Cited by 117
“role of antibiotic timing in disease outcome, but final evidence is still lacking [5, 12].”
BackgroundThe blood-brain barrier and nasal drug delivery to the central nervous system
Miyake, M. M., & Bleier, B. S. (2015) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2015.29.4149 · Cited by 106
Evaluation of an Antimicrobial Stewardship Program at a Pediatric Teaching Hospital
Metjian, T. A., Prasad, P. A., Kogon, A. J., Coffin, S. E., & Zaoutis, T. E. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318158603a · Cited by 112
Odabaşı, I. Ö. (2020) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.14744/semb.2020.00236 · Cited by 239
Archimbaud, C., Chambon, M., Bailly, J. L., Petit, I., Henquell, C., Mirand, A., Aublet‐Cuvelier, B., Ughetto, S., Beytout, J., Clavelou, P., et al. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21330 · Cited by 105
Imberti, R., Cusato, M. P., Accetta, G., Marinò, V., Procaccio, F., Gaudio, A. D., Iotti, G. A., & Regazzi, M. B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00231-12 · Cited by 104
“(27), but the optimal IVT/intrathecal dosing regimen for CMS”
BackgroundDexamethasone and long‐term outcome in adults with bacterial meningitis
Weisfelt, M., Hoogman, M., van de Beek, D., de Gans, J., Dreschler, W. A., & Schmand, B. A. (2006) · Annals of Neurology · doi:10.1002/ana.20944 · Cited by 105
“come routine therapy in adults with suspected bacterial meningitis.(2,6,8)”
BackgroundMace, S. E. (2008) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2008.02.002 · Cited by 146
“This is because of studies indicating dexamethasone is associated with a higher therapeutic failure rates and may decrease the CSF levels of various antibiotics, such as vancomycin (see Tables 2 and 4, and the adjuvant therapy section) [57,58].”
BackgroundInfluentialSepsis and Other Infectious Disease Emergencies in the Elderly
Liang, S. Y. (2016) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2016.04.005 · Cited by 133
Remeš, F., Tomáš, R., Jindrák, V., Vaniš, V., & Šetlík, M. (2013) · Journal of neurosurgery · doi:10.3171/2013.6.jns122126 · Cited by 106
Acute Bacterial Meningitis in Infants and Children: Epidemiology and Management
Agrawal, S., & Nadel, S. (2011) · Pediatric Drugs · doi:10.2165/11593340-000000000-00000 · Cited by 99
Cost-Effective Diagnostic Checklists for Meningitis in Resource-Limited Settings
Durski, K. N., Kuntz, K. M., Yasukawa, K., Virnig, B. A., Meya, D. B., & Boulware, D. R. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31828e1e56 · Cited by 101
The remaining challenges of pneumococcal disease in adults
Ludwig, E., Bonanni, P., Rohde, G. G. U., Sayıner, A., & Torres, A. (2012) · European Respiratory Review · doi:10.1183/09059180.00008911 · Cited by 103
Group B Streptococcal Neonatal Meningitis
Tavares, T., Pinho, L., & Andrade, E. B. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00079-21 · Cited by 111
“A computerized tomography scan may also be helpful before performing a lumbar puncture in cases of suspected increased intracranial pressure, such as focal findings in the neurological exam (148).”
BackgroundErdem, H., İnan, A., Guven, E., Hargreaves, S., Larsen, L., Shehata, G. A., Pernicová, E., Khan, E. A., Baštáková, L., Namani, S. A., et al. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2973-0 · Cited by 117
“In the literature, pneumococcal and listerial CNS diseases have been known to be quite frequent in elderly patients [4, 27].”
BackgroundHeckenberg, S. G. B., Brouwer, M. C., & van de Beek, D. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4088-7.00093-6 · Cited by 152
Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine
Yildirim, I. B., Shea, K. M., & Pelton, S. I. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.07.009 · Cited by 104
“According to the 2004 Infectious Diseases Society of America practice guidelines for bacterial meningitis, vancomycin plus either ceftriaxone or cefotaxime is recommended for suspected bacterial meningitis.(55) We continue to use this combination despite the decline in serotype 19A prevalence in the community, as most…”
Erdem, H., Ulu-Kılıç, A., Kılıç, S., Karahocagil, M. K., Shehata, G. A., Tülek, N., Yetkin, F., Çelen, M. K., Ceran, N., Gül, H. C., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05974-11 · Cited by 97
“In addition, oral antibiotics are not recommended for the management of acute central nervous system infections (11, 27).”
BackgroundCommunity‐Acquired Bacterial Meningitis in Older People
Weisfelt, M., van de Beek, D., Spanjaard, L., Reitsma, J. B., & de Gans, J. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00878.x · Cited by 112
Heparin-binding protein: A diagnostic marker of acute bacterial meningitis*
Linder, A., Åkesson, P., Brink, M., Studahl, M., Björck, L., & Christensson, B. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318206c396 · Cited by 98
“Clinical features of patients with bacterial and viral infections of the central nervous system may be remarkably similar and CSF findings inconclusive (3).”
BackgroundChandrashekara, S. (2012) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.103235 · Cited by 103
“antimicrobial depending upon the sensitivity, with adequate symptom control and other supportive measures.[25-27] Recommendations broadly suggest to initiate an antibiotic after”
Ng, K., Mabasa, V. H., Chow, I., & Ensom, M. H. H. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9784-z · Cited by 96
Paterson, D. L. (2008) · Clinical Infectious Diseases · doi:10.1086/590062 · Cited by 99
Thompson, C., Kneen, R., Riordan, A., Kelly, D. F., & Pollard, A. J. (2011) · Archives of Disease in Childhood · doi:10.1136/archdischild-2011-300100 · Cited by 113
Harz, M., Kiehntopf, M., Stöckel, S., Rösch, P., Straube, E., Deufel, T., & Popp, J. (2009) · Journal of Biophotonics · doi:10.1002/jbio.200810068 · Cited by 94
Davis, L. E. (2018) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000660 · Cited by 125
Arslan, F., Meynet, E., Sünbül, M., Sıpahı, O. R., Kurtaran, B., Kaya, S., İnkaya, A. Ç., Pagliano, P., Şengöz, G., Batırel, A. A., et al. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2346-5 · Cited by 106
“Despite the high yield (67–90 %) of CSF Gram staining performed under suitable conditions in bacterial meningitis, the rates are significantly lower (nearly 30 %) in cases of neuroinvasive listeriosis [19, 20].”
BackgroundACR Appropriateness Criteria Headache
Douglas‐Akinwande, A. C., Wippold, F. J., Broderick, D. F., Aiken, A. H., Amin‐Hanjani, S., Brown, D. C., Corey, A. S., Germano, I. M., Hadley, J. A., Jagadeesan, B., et al. (2014) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2014.03.024 · Cited by 94
“According to the Infectious Diseases Society of America [69], when any underlying condition is present, blood cultures should first be obtained, and then empiric antimicrobial therapy instituted, followed by CT of the brain without and with contrast to look for contraindications to lumbar puncture.”
MethodKwambana-Adams, B., Asiedu‐Bekoe, F., Sarkodie, B., Afreh, O. K., Kuma, G. K., Owusu-Okyere, G., Foster-Nyarko, E., Ohene, S.-A., Okot, C. L., Worwui, A. K., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1914-3 · Cited by 94
Nosocomial bacterial meningitis in adults: a prospective series of 50 cases
Weisfelt, M., van de Beek, D., Spanjaard, L., & de Gans, J. (2007) · Journal of Hospital Infection · doi:10.1016/j.jhin.2007.02.017 · Cited by 89
Aminoglycoside therapy in infectious diseases
Poulikakos, P., & Falagas, M. E. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.806486 · Cited by 103
“agalactiae or Listeria monocytogenes and in children were an enteric Gram-negative pathogen is the presumed cause of infection [61].”
BackgroundMethodReliable Detection of Group B Streptococcus in the Clinical Laboratory
Rosa-Fraile, M., & Spellerberg, B. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00582-17 · Cited by 90
“Although these tests can help in the diagnosis of neonatal GBS meningitis when no visible or viable microorganisms are present, the routine use of latex agglutination testing for the etiological diagnosis of bacterial meningitis has been questioned (1, 48).”
BackgroundCascio, A., Conti, A., Sinardi, L., Iaria, C., Angileri, F. F., Stassi, G., David, T., Versaci, A., Iaria, M., & David, A. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.06.032 · Cited by 91
“Even if the CSF sterilization was obtained after fewer than 5 days of therapy in 75% of the reported cases, we think that when possible, the recommendations of IDSA should be followed, and that antimicrobial therapy be continued until CSF culture results remain negative for 10–14 consecutive days before a new CSF shun…”
BackgroundTuberculous meningitis: Diagnostic and therapeutic challenges
Chin, J. H. (2014) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000023 · Cited by 93
Nagano, N., Nagano, Y., Kimura, K., Tamai, K., Yanagisawa, H., & Arakawa, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00596-08 · Cited by 89
“Once the test result is positive for the GBS antigen, specific therapy is initiated with penicillin or ampicillin plus gentamicin (30, 38), because GBS is considered to be uniformly susceptible to these drugs.”
D’Angelo, G., Pilla, R., Tascini, C., & Rampone, S. (2019) · Soft Computing · doi:10.1007/s00500-018-03729-y · Cited by 90
Current Landscape and Future Perspective of Oxazolidinone Scaffolds Containing Antibacterial Drugs
Zhao, Q., Xin, L., Liu, Y., Liang, C., Li, J., Jian, Y., Li, H., Shi, Z., Liu, H., & Cao, W. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00480 · Cited by 88
Egi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Acute Medicine & Surgery · doi:10.1002/ams2.659 · Cited by 96
Combatting resistant enterococcal infections: a pharmacotherapy review
Mercuro, N. J., Davis, S. L., Zervos, M., & Herc, E. S. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1479397 · Cited by 98
Sonographic findings in bacterial meningitis in neonates and young infants
Yıkılmaz, A., & Taylor, G. A. (2007) · Pediatric Radiology · doi:10.1007/s00247-007-0538-6 · Cited by 87
“Although other gram-negative enteric organisms such as Klebsiella species and Citrobacter species are less common, they can have far more devastating consequences [15].”
BackgroundManagement of acute meningitis
Griffiths, M. J., McGill, F., & Solomon, T. (2018) · Clinical Medicine · doi:10.7861/clinmedicine.18-2-164 · Cited by 87
Wang, J.-H., Lin, P., Chou, C.-H., Ho, C., Lin, K., Tsai, C.-T., Wang, J.-H., Chi, C.-Y., & Ho, M. (2012) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2012.08.028 · Cited by 85
Herwald, H., Korte, W., Allanore, Y., Denton, C. P., Matucci‐Cerinic, M., & Dickneite, G. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-07-0625 · Cited by 86
“While a recombinant FXIII-2A product (NovoThirteen®/Tretten®, NovoNordisk A/S, Copenhagen, Denmark) is licensed in European Union countries, Canada, and most recently in the USA, for use in patients with congenital FXIII A-subunit deficiency , this product is not licensed for patients who have a deficiency in the FXII…”
LeBras, M. H., Chow, I., Mabasa, V. H., & Ensom, M. H. H. (2016) · Neurocritical Care · doi:10.1007/s12028-016-0269-3 · Cited by 85
Community-acquired bacterial meningitis in adults
Schut, E. S., de Gans, J., & van de Beek, D. (2008) · Practical Neurology · doi:10.1136/jnnp.2007.139725 · Cited by 85
“Several prediction rules combining serum and CSF markers to exclude bacterial meningitis have been published, especially for children, but their use for clinical decisions in individual patients is discouraged by the bacterial meningitis guideline of the Infectious Disease Society of America.(18)”
Therapeutic options forAcinetobacter baumanniiinfections: an update
Vilà, J., & Pachón, J. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.729820 · Cited by 85
“Thus, although the Infectious Diseases Society of America Guidelines for the management of bacterial meningitis recommends a colistin dosage of 125,000 IU/day [82], the optimal conditions of use of intrathecal or intraventricular colistin in A.”
BackgroundInfluentialMechanisms of β-lactam killing and resistance in the context of Mycobacterium tuberculosis
Wivagg, C. N., Bhattacharyya, R. P., & Hung, D. T. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.94 · Cited by 96
Singh, H., Thangaraju, P., & Chakrabarti, A. (2013) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2013/6337.3626 · Cited by 83
“[28] Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al.”
BackgroundMethodMaking the change to area under the curve–based vancomycin dosing
Heil, E. L., Claeys, K. C., Mynatt, R. P., Hopkins, T. L., Brade, K. D., Watt, I., Rybak, M. J., & Pogue, J. M. (2018) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp180034 · Cited by 86
Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections
Kim, U. J., Kim, H. K., An, J. H., Cho, S. K., Park, K., & Jang, H. (2014) · Chonnam Medical Journal · doi:10.4068/cmj.2014.50.2.37 · Cited by 88
“Because colistin has difficulty penetrating the blood-brain barrier, intra-ventricular administration of colistin is recommended for CRAB infections and Acinetobacter meningitis, as well during the removal of infected hardware.(39,40) Colistin-based combination therapies in patients with CRAB infections remain controv…”
Background千葉, 菜., Morozumi, M., Sunaoshi, K., Takahashi, S., Takano, M., Komori, T., Sunakawa, K., & Ubukata, K. (2009) · Epidemiology and Infection · doi:10.1017/s0950268809990239 · Cited by 81
“According to USA guidelines [31], the use of thirdgeneration cephalosporins – CTX, CRO, or either of these in combination with VAN – is recommended for meningitis caused by PRSP.”
Tängdén, T., Enblad, P., Ullberg, M., & Sjölin, J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir197 · Cited by 83
“Postneurosurgical ventriculomeningitis is typically caused by Staphylococcus aureus or coagulasenegative staphylococci [3, 4].”
BackgroundHaddad, N., Carr, M., Balian, S., Lannin, J., Kim, Y., Toth, C., & Jarvis, J. (2022) · Antibiotics · doi:10.3390/antibiotics11121843 · Cited by 96
“Ampicillin has long been part of empiric meningitis treatment, particularly for niche coverage against Listeria monocytogenes in adults 50 years and older [54].”
BackgroundWatkins, R., Lemonovich, & File, T. M. (2012) · Core evidence · doi:10.2147/ce.s33430 · Cited by 87
“86 The recently published guidelines on DFIs recommend linezolid as one of the drugs to treat MRSA and also note that it has been shown to be effective in clinical trials including patients with DFIs.”
Proposal for shorter antibiotic therapies
Wintenberger, C., Guery, B. P., Bonnet, É., Castan, B., Cohen, R., Diamantis, S., Lesprit, P., Maulin, L., Pean, Y., Péju, E., et al. (2017) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2017.01.007 · Cited by 90
Ommaya reservoir infections: A 16-year retrospective analysis
Mead, P. A., Safdieh, J. E., Nizza, P., Tuma, S., & Sepkowitz, K. A. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.11.014 · Cited by 78
Graf, E. H., Farquharson, M. V., & Cárdenas, A. M. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.09.022 · Cited by 71
Characterization of a pneumococcal meningitis mouse model
Mook-Kanamori, B. B., Geldhoff, M., Troost, D., van der Poll, T., & van de Beek, D. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-71 · Cited by 76
“The role of microglia during pneumococcal meningitis is largely unknown at present, but interest has been fueled by the observation that microglial activation in vitro is limited by corticosteroids treatment [40], which has become the standard adjuvant therapy in the treatment of bacterial meningitis in many countries…”
BackgroundNishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Acute Medicine & Surgery · doi:10.1002/ams2.322 · Cited by 85
Clinical decision rules to distinguish between bacterial and aseptic meningitis
Dubos, F. (2006) · Archives of Disease in Childhood · doi:10.1136/adc.2005.085704 · Cited by 77
Adjunctive dexamethasone in adults with meningococcal meningitis
Heckenberg, S. G. B., Brouwer, M. C., van der Ende, A., van de Beek, D., Wennekes, M., Esselink, R., de Graaf, R., ten Houten, R., Baart, J., Keunen, R., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e2684 · Cited by 75
Use of C-reactive protein to tailor antibiotic use: a systematic review and meta-analysis
Petel, D. S., Winters, N., Gore, G. C., Papenburg, J., Beltempo, M., Lacroix, J., & Fontela, P. S. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022133 · Cited by 82
Erdem, H., Cag, Y., Ozturk-Engin, D., Defres, S., Kaya, S., Larsen, L., Poljak, M., Barsic, B., Argemi, X., Sørensen, S. M., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05016-14 · Cited by 74
“Meningoencephalitis was defined as a clinical, radiological, and/or laboratory presentation compatible with encephalitis (3, 8, 14) and meningitis (1, 15).”
BackgroundPenetration of Vancomycin into the Cerebrospinal Fluid: A Systematic Review
Beach, J. E., Perrott, J. L., Turgeon, R. D., & Ensom, M. H. H. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0548-y · Cited by 73
Escherichia Coli Meningitis Features in 325 Children From 2001 to 2013 in France
Basmaci, R., Bonacorsi, S., Bidet, P., Biran, V., Aujard, Y., Bingen, É., Béchet, S., Cohen, R., & Lévy, C. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ367 · Cited by 73
“treatment should be continued at least for the recommended 21 days [25].”
BackgroundVikse, J., Henry, B. M., Roy, J., Ramakrishnan, P. K., Tomaszewski, K. A., & Walocha, J. A. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.07.011 · Cited by 73
“stains, often results in patients receiving empiric antibiotic therapy.(18,19) This can lead to potential adverse effects, increased health care costs, and an increased risk of nosocomial infection.”
Guidelines for Antibiotic Prescription in Intensive Care Unit
Guleria, R., Mohan, A., Kulkarni, A. P., Madan, K., & Hadda, V. (2019) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23101 · Cited by 94
Soucek, D. K., Dumkow, L. E., VanLangen, K. M., & Jameson, A. P. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190017737697 · Cited by 72
“Additional empiric regimens may include ampicillin for patients with Listeria monocytogenes risk factors (eg, age >50 years, pregnancy, newborn, or immunocompromise) or acyclovir for suspected herpes virus infection.(1,2) The turnaround time for CSF cultures may take several days, approximately 48 hours for bacterial…”
BackgroundMeningococcal disease, a clinical and epidemiological review
Siqueira‐Batista, R., Gomes, A. P., Gazineo, J. L. D., Miguel, P. S. B., Santana, L. A., Oliveira, L., & Geller, M. (2017) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2017.10.004 · Cited by 93
“Cefotaxime should be administered intravenously, at the dose of 50 mg/kg every 4 or 6 h (maximum dose of 12 mg/d) [60].”
BackgroundInfluentialMulticenter Evaluation of Vancomycin Dosing: Emphasis on Obesity
Hall, R. G., Payne, K. D., Bain, A. M., Rahman, A. P., Nguyen, S., Eaton, S. A., Busti, A. J., Vu, S. L., & Bedimo, R. G. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.01.046 · Cited by 73
Management of Acute Bacterial Meningitis in Children
Alamarat, Z. I., & Hasbun, R. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s240162 · Cited by 100
Metadata
- Authors
- Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J.
- Affiliations
- Drexel University (US)
- Weill Cornell Medical Center (US)
- Baylor College of Medicine (US)
- Medical College of Wisconsin (US)
- Indiana University School of Medicine (US)
- University of Virginia (US)
- University of Alabama at Birmingham (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-11-01
- Volume
- 39
- Issue
- 9
- Pages
- 1267-1284
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2143206150
- Cited by
- 2,308
- References
- 137
- Citations by year
- 2026: 111 · 2025: 99 · 2024: 101 · 2023: 83 · 2022: 115 · 2021: 131 · 2020: 125 · 2019: 128 · 2018: 116 · 2017: 142 · 2016: 121 · 2015: 142 · 2014: 102 · 2013: 128 · 2012: 117
- FWCI
- 44.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- bacterial meningitis, diagnosis, management, antimicrobial therapy, clinical guidelines
- MeSH terms
- Adult, Algorithms, Anti-Bacterial Agents, Cerebrospinal Fluid Shunts, Child, Humans, Infant, Infant, Newborn, Meningitis, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.